News | News By Subject | News by Disease News By Date | Search News

Peripheral arterial disease News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
AstraZeneca PLC (AZN) Suffers Another Blow After Blood-Thinning Drug Flunks Trial     10/4/2016
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Merck & Co., Inc. (MRK) Release: FDA Approves ZONTIVITY™ (Vorapaxar), First-In-Class PAR-1 Antagonist, For The Reduction Of Thrombotic Cardiovascular Events In Patients With A History Of Heart Attack Or With Peripheral Arterial Disease     5/12/2014
Valentis, Inc. (VLTS) Ends Lead Drug Development After Mid-Stage Study Failure     7/11/2006
Vasogen (VSGN) Says Celacade Did Not Meet Phase 3 Primary Goal     3/13/2006
Dainippon Pharmaceutical, Sumitomo Pharmaceuticals Co. Ltd. And Ono Pharmaceutical Company, Ltd. To Enter Into Joint Development And Marketing Agreement For Limaprost Alfadex, Oral PGE1 Derivative     12/7/2005
Vasogen (VSGN) Gives Update On Phase III Celacade Trials     12/7/2005
Angiotech Pharmaceuticals (ANPI) Announces Acquisition Of Afmedica, Inc.     9/13/2005
Vasogen (VSGN) Stops Celacade Phase III Trial Early     8/30/2005
Endovasc Inc. (EVSC) Issues Update On Angiogenix; Cease Funding Research By Its Subsidiary, Angiogenix Limited, Inc.     5/26/2005
Endovasc Inc. (EVSC) Receives Feedback From The FDA Regarding Liprostin     5/2/2005
Sangamo BioSciences' (SGMO) Partner Edwards Lifesciences (EW) Files Investigational New Drug Application For Phase I/II "AVENGE" Clinical Trial     2/11/2004
NicOx SA (FR:N07413) Release: NCX 4016 Successfully Achieves Primary Efficacy Endpoint In Phase II Clinical Study Of Symptomatic Peripheral Arterial Obstructive Disease (PAOD)     1/8/2004

News from Around the Web

Press Releases
Shockwave Medical Announces Positive Six-Month DISRUPT PAD Results In Patients With Calcified Peripheral Artery Disease     9/19/2016
FDA Clears Shockwave Medical's Lithoplasty System, the First-Ever Device That Uses Sound Waves for Peripheral Artery Disease     9/16/2016
W. L. Gore & Associates VIABAHN Endoprosthesis Marks 20 Years Of Proven Performance     9/7/2016
Shockwave Medical Announces Positive Study Results Of Novel Lithoplasty System To Treat Peripheral Artery Disease     4/27/2016
Proteon (PRTO) Announces Publication In The Journal Of Cardiovascular Pharmacology Of Promising Nonclinical Results For Vonapanitase In Peripheral Artery Disease     4/13/2016
Profusa Awarded $1.75M NIH Grant To Further Develop Tissue-Integrated Biosensors For Continuous Oxygen Monitoring In PAD Patients     4/11/2016
SurModics (SRDX) Announces First Patient Enrolled In IDE Study Of Surveil Drug-Coated Balloon     4/6/2016
Holy Name Medical Center Enrolls First U.S. Patient In Ground-Breaking Gene Therapy Clinical Trial     2/5/2016
Hemostemix Poised To Expand Phase-2 Clinical Trial Of Lead Product ACP-01 To The United States     12/22/2015
Resverlogix (RVX.TO) Presents Important New Data At The Annual American Society of Nephrology Kidney Week Conference     11/9/2015
Symic Biomedical Advances First Product Candidate, SB-030, Into Clinical Development With Treatment Of First Patient In SHIELD Trial     10/27/2015
Proteon Therapeutics, Inc. (PRTO) Announces Results From Phase I Study Of Investigational Drug Vonapanitase In Patients With Symptomatic Peripheral Artery Disease Presented At TCT 2015     10/12/2015
Proteon Therapeutics, Inc. (PRTO) Announces Top-Line Results From Phase I Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease     8/14/2015
Symic Biomedical Selects Vascular Clinical Candidate     7/20/2015
Merck & Co. (MRK) Release: Two New Post-Hoc Analyses Of TRA 2°P TIMI 50 Study Showed ZONTIVITY (Vorapaxar) Added To Aspirin And/Or Clopidogrel Reduced Acute Limb Ischemia And Peripheral Revascularizations, Respectively, In Certain Patients With Peripheral Arterial Disease     3/5/2015

//-->